Nova Leap Health Toekomstige groei
Future criteriumcontroles 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Nova Leap Health.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
| Healthcare winstgroei | 63.3% |
| Inkomstengroei | n/a |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 29 Oct 2024 |
Recente toekomstige groei-updates
Geen updates
Recent updates
Nova Leap Health Corp.'s (CVE:NLH) 35% Share Price Surge Not Quite Adding Up
Oct 31
Risks Still Elevated At These Prices As Nova Leap Health Corp. (CVE:NLH) Shares Dive 27%
Sep 12Nova Leap Health Corp.'s (CVE:NLH) 33% Price Boost Is Out Of Tune With Revenues
Jun 08Should Shareholders Reconsider Nova Leap Health Corp.'s (CVE:NLH) CEO Compensation Package?
May 31Nova Leap Health Corp. (CVE:NLH) Looks Just Right With A 28% Price Jump
Mar 23Market Participants Recognise Nova Leap Health Corp.'s (CVE:NLH) Revenues
Jan 06Nova Leap Health Corp. (CVE:NLH) Investors Are Less Pessimistic Than Expected
Jul 29Does Nova Leap Health (CVE:NLH) Have A Healthy Balance Sheet?
Feb 22Calculating The Intrinsic Value Of Nova Leap Health Corp. (CVE:NLH)
Aug 17Nova Leap Health (CVE:NLH) Is Carrying A Fair Bit Of Debt
May 14Estimating The Intrinsic Value Of Nova Leap Health Corp. (CVE:NLH)
Oct 22Nova Leap Health (CVE:NLH) Strong Profits May Be Masking Some Underlying Issues
Mar 18In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Nova Leap Health onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.
Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2024 | 27 | N/A | N/A | N/A | 1 |
| 6/30/2024 | 26 | 0 | 2 | 2 | N/A |
| 3/31/2024 | 26 | 0 | 2 | 2 | N/A |
| 12/31/2023 | 26 | -1 | 2 | 2 | N/A |
| 9/30/2023 | 26 | -1 | 1 | 1 | N/A |
| 6/30/2023 | 27 | -1 | 2 | 2 | N/A |
| 3/31/2023 | 27 | -1 | 1 | 1 | N/A |
| 12/31/2022 | 28 | -1 | 1 | 1 | N/A |
| 9/30/2022 | 27 | -1 | 2 | 2 | N/A |
| 6/30/2022 | 25 | 0 | 2 | 2 | N/A |
| 3/31/2022 | 24 | 0 | 3 | 3 | N/A |
| 12/31/2021 | 21 | 2 | 2 | 2 | N/A |
| 9/30/2021 | 20 | 4 | 1 | 1 | N/A |
| 6/30/2021 | 19 | 3 | 2 | 2 | N/A |
| 3/31/2021 | 18 | 2 | 3 | 3 | N/A |
| 12/31/2020 | 17 | 1 | 3 | 3 | N/A |
| 9/30/2020 | 18 | 0 | 3 | 3 | N/A |
| 6/30/2020 | 18 | -1 | 1 | 1 | N/A |
| 3/31/2020 | 18 | 0 | 1 | 1 | N/A |
| 12/31/2019 | 17 | -1 | 1 | 1 | N/A |
| 9/30/2019 | 16 | -1 | 0 | 0 | N/A |
| 6/30/2019 | 15 | -1 | 0 | 0 | N/A |
| 3/31/2019 | 13 | -1 | -1 | -1 | N/A |
| 12/31/2018 | 10 | -1 | -2 | -2 | N/A |
| 9/30/2018 | 7 | -1 | -1 | -1 | N/A |
| 6/30/2018 | 5 | -1 | -1 | -1 | N/A |
| 3/31/2018 | 2 | -1 | N/A | -1 | N/A |
| 12/31/2017 | 1 | -1 | N/A | -1 | N/A |
| 12/31/2016 | 0 | 0 | N/A | 0 | N/A |
| 10/31/2016 | 0 | 0 | N/A | 0 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if NLH's forecast earnings growth is above the savings rate (2.2%).
Winst versus markt: Insufficient data to determine if NLH's earnings are forecast to grow faster than the Canadian market
Hoge groeiwinsten: Insufficient data to determine if NLH's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: Insufficient data to determine if NLH's revenue is forecast to grow faster than the Canadian market.
Hoge groei-inkomsten: Insufficient data to determine if NLH's revenue is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if NLH's Return on Equity is forecast to be high in 3 years time